2017 年 43 巻 11 号 p. 654-660
The clinical condition of patients in intensive care units (ICU) fluctuates significantly. The pharmaceutical-information service is provided by clinical pharmacists. However, the types of pharmaceutical information that merit intervention by clinical pharmacists in the intensive care field are unclear. In this study, we systematically constructed pharmaceutical-information services to clarify the condition in which intervention by clinical pharmacists is allowed for drug therapies in the intensive care field.
We investigated clinical pharmacists' interventions in the ICU from June 2013 to December 2014 (excluding the term from February 2014 to March 2014), and constructed a categorization by referring to the pharmaceutical interview form (IF). We configured “the necessity for the drug therapy” in addition to IF categories, because there were several inquiries by the pharmacists as to whether the medication should be started or discontinued. Then we classified clinical pharmacists' interventions from February 2016 to November 2016 using that categorization. During that period, there were 840 cases, and the most common category was “the necessity for drug therapy” which numbered 191 cases. Therefore, of all the cases there were 412 cases labeled “preavoid” in which the interventions improved the safety of the medication..
In this study, it was revealed that intervention by the clinical pharmacists positively identified the necessity for drug therapy. It seems that the clinical pharmacists require the ability to comprehend clinical conditions and evaluate drug therapies. An evaluation of “preavoid” cases using the categorization suggests pharmacists contribute to improvements in the quality and the safety of medication.
